• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响孕妇在尼日利亚阿布贾 Bwari 地区初级保健机构接受间歇性预防治疗的因素。

Factors influencing the use of intermittent preventive treatment of pregnant women seeking care at primary healthcare facilities in the Bwari Area Council, Abuja, Nigeria.

机构信息

Discipline of Family Medicine, College of Health Sciences, University of Kwazulu-Natal, Durban.

出版信息

Afr J Prim Health Care Fam Med. 2020 Apr 16;12(1):e1-e8. doi: 10.4102/phcfm.v12i1.2256.

DOI:10.4102/phcfm.v12i1.2256
PMID:32370528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7203208/
Abstract

BACKGROUND

The use of intermittent preventive treatment-sulphadoxine-pyrimethamine (IPT-SP), adapted by Nigeria, is one key preventive strategy recommended by the World Health Organization. Because antenatal clinics serve as the usual entry point for IPT-SP implementation, this study explored healthcare workers' knowledge and practice, which are key to optimal IPT-SP coverage.

AIM

This study aimed to explore the knowledge and practices of healthcare workers on the direct observation of IPT-SP amongst pregnant women attending antenatal care (ANC) in the Bwari Area Council (BWAC) of the Federal Capital Territory, Abuja, Nigeria.

SETTING

The study took place at five different wards of Bwari Area Council and eight Antenatal care facilities in Abuja, Federal Capital Territory, Nigeria.

METHODS

In-depth interviews and indirect observations were conducted among purposively selected healthcare workers in charge of the ANC of the eligible facilities. The study explored the knowledge and practices of healthcare workers on intermittent preventive treatment. Data were transcribed, translated and manually coded, and thematic analysis was conducted.

RESULTS

Healthcare workers' knowledge of IPT-SP, mode of administration and the rationale behind the use were poor. They all agreed that IPT-SP is supposed to be administered as a directly observed therapy at the clinic, but this practice was non-existent.

CONCLUSION

The findings indicate that factors such as adequate technical skill, accessibility and availability of logistics influence knowledge and practice of IPT service delivery. Therefore, measures should be put in place to address gaps identified by this study.

摘要

背景

尼日利亚采用的间歇性预防治疗-磺胺多辛/乙胺嘧啶(IPT-SP)是世界卫生组织推荐的一项关键预防策略。由于产前诊所是 IPT-SP 实施的常规切入点,因此本研究探讨了医护人员的知识和实践,这是实现最佳 IPT-SP 覆盖率的关键。

目的

本研究旨在探索在尼日利亚阿布贾联邦首都特区(Bwari Area Council,BWAC)接受产前护理(ANC)的孕妇中,医护人员对直接观察 IPT-SP 的知识和实践。

地点

研究在尼日利亚阿布贾联邦首都特区 Bwari 区的五个不同病房和八个产前护理设施进行。

方法

对符合条件的设施的 ANC 负责的医护人员进行了深入访谈和间接观察。本研究探讨了医护人员对间歇性预防治疗的知识和实践。对数据进行了转录、翻译和手动编码,并进行了主题分析。

结果

医护人员对 IPT-SP、给药方式和使用理由的知识不足。他们都同意 IPT-SP 应该在诊所作为直接观察治疗来管理,但这种做法并不存在。

结论

研究结果表明,诸如足够的技术技能、后勤的可及性和可用性等因素会影响 IPT 服务提供的知识和实践。因此,应采取措施解决本研究中发现的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d22/7203208/ef1a90acc918/PHCFM-12-2256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d22/7203208/93148a006046/PHCFM-12-2256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d22/7203208/ef1a90acc918/PHCFM-12-2256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d22/7203208/93148a006046/PHCFM-12-2256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d22/7203208/ef1a90acc918/PHCFM-12-2256-g002.jpg

相似文献

1
Factors influencing the use of intermittent preventive treatment of pregnant women seeking care at primary healthcare facilities in the Bwari Area Council, Abuja, Nigeria.影响孕妇在尼日利亚阿布贾 Bwari 地区初级保健机构接受间歇性预防治疗的因素。
Afr J Prim Health Care Fam Med. 2020 Apr 16;12(1):e1-e8. doi: 10.4102/phcfm.v12i1.2256.
2
Factors influencing intermittent preventive treatment for malaria prevention among pregnant women accessing antenatal care in selected primary health care facilities of Bwari Area Council, Abuja Nigeria.影响尼日利亚阿布贾 Bwari 地区理事会选定初级卫生保健设施中接受产前保健的孕妇间歇性预防治疗疟疾的因素。
PLoS One. 2022 Dec 15;17(12):e0277877. doi: 10.1371/journal.pone.0277877. eCollection 2022.
3
Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria.尼日利亚孕期使用周效磺胺-乙胺嘧啶预防疟疾的不平等现象。
Malawi Med J. 2020 Mar;32(1):45-51. doi: 10.4314/mmj.v32i1.9.
4
Compliance with intermittent preventive treatment during pregnancy among postpartum women in Ibadan, Nigeria.尼日利亚伊巴丹产后妇女孕期间歇性预防治疗的依从性
Afr J Med Med Sci. 2014 Mar;43(1):67-74.
5
Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.尼日利亚奥约州奥格博莫索初级卫生保健中心产前诊所就诊妇女疟疾间歇性预防治疗的决定因素
Pan Afr Med J. 2019 Jun 11;33:101. doi: 10.11604/pamj.2019.33.101.14800. eCollection 2019.
6
Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.尼日利亚西南部农村地区初级卫生保健中心产前诊所孕妇对疟疾间歇性预防治疗的知晓与应用:一项横断面研究
BMC Pregnancy Childbirth. 2009 Jul 9;9:28. doi: 10.1186/1471-2393-9-28.
7
Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.马拉维采用世界卫生组织更新的政策后,使用磺胺多辛-乙胺嘧啶进行间歇性预防治疗疟疾在孕妇中的应用:2015-2016 年人口与健康调查分析。
BMC Public Health. 2020 Mar 16;20(1):335. doi: 10.1186/s12889-020-08471-5.
8
Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.群组与个体产前护理对尼日利亚和肯尼亚孕妇间歇性预防治疗疟疾的接受率和相关疟疾结局的影响:一项实用型群组随机试验的数据分析。
Malar J. 2020 Jan 29;19(1):51. doi: 10.1186/s12936-020-3099-x.
9
Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.在尼日利亚西南部的伊巴丹,使用周效磺胺-乙胺嘧啶进行间歇性预防治疗对预防孕产妇和胎盘疟疾有效。
Malar J. 2007 Jul 6;6:88. doi: 10.1186/1475-2875-6-88.
10
Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chókwè district, Southern Mozambique.在莫桑比克南部乔奎地区进行的一项定性研究:获得和使用预防疟疾孕期间歇性治疗的情况。
PLoS One. 2019 Jan 24;14(1):e0203740. doi: 10.1371/journal.pone.0203740. eCollection 2019.

引用本文的文献

1
Perspectives of postpartum women on intermittent presumptive treatment in Uganda: implications for malaria prevention: a qualitative study.乌干达产后妇女对间歇性推定治疗的看法:对疟疾预防的影响:一项定性研究。
Malar J. 2024 Nov 6;23(1):331. doi: 10.1186/s12936-024-05135-2.
2
Perceptions of sulphadoxine-pyrimethamine use among pregnant women in sub-Saharan Africa: a scoping review.撒哈拉以南非洲地区孕妇对磺胺多辛-乙胺嘧啶使用情况的认知:一项范围综述
Malariaworld J. 2023 Apr 6;14:1. doi: 10.5281/zenodo.7828460. eCollection 2023.
3
Factors influencing intermittent preventive treatment for malaria prevention among pregnant women accessing antenatal care in selected primary health care facilities of Bwari Area Council, Abuja Nigeria.

本文引用的文献

1
MISSED OPPORTUNITIES FOR INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA IN PREGNANCY IN NIGERIA: EVIDENCE FROM DEMOGRAPHIC AND HEALTH SURVEY IN NIGERIA 2013.尼日利亚孕期疟疾间歇性预防治疗的错失机会:来自2013年尼日利亚人口与健康调查的证据
Ann Ib Postgrad Med. 2017 Dec;15(2):88-95.
2
Perspectives of health care providers on the provision of intermittent preventive treatment in pregnancy in health facilities in Malawi.马拉维医疗机构中医疗服务提供者对孕期间歇性预防治疗的看法。
BMC Health Serv Res. 2015 Aug 29;15:354. doi: 10.1186/s12913-015-0986-x.
3
Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.
影响尼日利亚阿布贾 Bwari 地区理事会选定初级卫生保健设施中接受产前保健的孕妇间歇性预防治疗疟疾的因素。
PLoS One. 2022 Dec 15;17(12):e0277877. doi: 10.1371/journal.pone.0277877. eCollection 2022.
4
Barriers and facilitators to access and uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in Nigeria: a scoping review.尼日利亚孕妇获取和采用磺胺多辛-乙胺嘧啶间歇性预防治疗的障碍与促进因素:一项范围综述
Malariaworld J. 2022 Feb 1;13:4. eCollection 2022.
5
Antenatal care positive responses to pregnant women in preventing and controlling malaria in pregnancy: the sub-Saharan African perspective.产前保健对撒哈拉以南非洲孕妇预防和控制妊娠疟疾的积极反应。
World J Pediatr. 2022 Jul;18(7):453-462. doi: 10.1007/s12519-022-00549-x. Epub 2022 May 26.
全球行动呼吁:最大化撒哈拉以南非洲地区孕期疟疾间歇性预防治疗对公共卫生的影响。
Malar J. 2015 May 18;14:207. doi: 10.1186/s12936-015-0728-x.
4
Malaria risk in Nigeria: Bayesian geostatistical modelling of 2010 malaria indicator survey data.尼日利亚的疟疾风险:2010年疟疾指标调查数据的贝叶斯地理统计建模
Malar J. 2015 Apr 14;14:156. doi: 10.1186/s12936-015-0683-6.
5
Access and use of interventions to prevent and treat malaria among pregnant women in Kenya and Mali: a qualitative study.肯尼亚和马里孕妇预防和治疗疟疾干预措施的获取与使用:一项定性研究。
PLoS One. 2015 Mar 23;10(3):e0119848. doi: 10.1371/journal.pone.0119848. eCollection 2015.
6
Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria.在尼日利亚阿比亚州和高原州大规模分发蚊帐之前的疟疾患病率、贫血症和基线干预措施覆盖率。
BMC Infect Dis. 2014 Mar 26;14:168. doi: 10.1186/1471-2334-14-168.
7
Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors.尼日利亚妊娠期间歇性预防治疗疟疾的服务提供不佳:提供者因素的影响。
Malar J. 2012 Sep 7;11:317. doi: 10.1186/1475-2875-11-317.
8
Low coverage of intermittent preventive treatment for malaria in pregnancy in Nigeria: demand-side influences.尼日利亚孕妇间歇性预防治疗疟疾覆盖率低:需求方影响。
Malar J. 2012 Mar 23;11:82. doi: 10.1186/1475-2875-11-82.
9
Knowledge of malaria and preventive measures among pregnant women attending antenatal clinics in a rural local government area in Southwestern Nigeria.尼日利亚西南部一个农村地方政府辖区内,在产前诊所就诊的孕妇对疟疾的了解及预防措施
World Health Popul. 2011;12(3):13-22. doi: 10.12927/whp.2011.22172.
10
Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria.尼日利亚中西部地区孕妇应用磺胺多辛-乙胺嘧啶间歇预防疗法治疗胎盘寄生虫感染的效果。
Int J Gynaecol Obstet. 2011 Jan;112(1):30-3. doi: 10.1016/j.ijgo.2010.07.027. Epub 2010 Oct 13.